Vida Strategic Partners President and CEO to Participate on Investor Relations Best Practices Panel at NIRI 2018
06. Juni 2018 07:57 ET
|
Vida Strategic Partners, Inc.
SAN FRANCISCO, June 06, 2018 (GLOBE NEWSWIRE) -- Vida Strategic Partners, an advisory firm supporting the financial, operational and communications goals of life science and healthcare companies,...
San Francisco Suicide Prevention Partners With Punk Rockers to Save Lives
05. März 2015 11:00 ET
|
Rock For Life
SAN FRANCISCO, CA--(Marketwired - Mar 5, 2015) - San Francisco Suicide Prevention (SFSP) announced today that they will once again partner with Global Affront, a San Francisco punk rock band, to...
Global Blood Therapeutics Announces First Cohort Dosed in Phase I/II Trial of GBT440 in Sickle Cell Disease
12. Januar 2015 07:35 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 12, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
Willie L. Brown, Jr. Joins the Board of Directors of Global Blood Therapeutics
08. Januar 2015 07:35 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 8, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
Global Blood Therapeutics Completes $48 Million Series B Financing
06. Januar 2015 07:35 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 6, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
Global Blood Therapeutics to Present at Upcoming Investor Conferences
05. Januar 2015 07:35 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 5, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood...
Global Blood Therapeutics' GBT440 Demonstrates Ability to Positively Impact Fundamental Sickle Cell Disease (SCD) Processes in Studies Presented at 2014 American Society of Hematology (ASH) Conference
08. Dezember 2014 10:00 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Dec 8, 2014) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, orally available therapeutics for the treatment of severe...
Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference
02. Dezember 2014 07:35 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, CA--(Marketwired - Dec 2, 2014) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, orally available therapeutics for the treatment of severe...